Farmakoterapia w Psychiatrii i Neurologii

Abstract

2/2021 vol. 37
Review paper

Relapse prevention in schizophrenia: expectations and reality

  1. 3rd Department of Psychiatry, Institute of Psychiatry and Neurology in Warsaw, Poland
Farmakoterapia w Psychiatrii i Neurologii 2021, 37 (2), 123–135
Online publish date: 2021/12/07
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Aim

The aim of the paper was to evaluate the practical prospects for preventing from relapsing or worsening in schizophrenia patients.

Selected literature review

Some of the recent publications deal with the prospects for preventing from relapsing or worsening symptoms in patients suffering from schizophrenia. This paper reviews publications highlighting the effectiveness of such prevention measures.

Conclusions

The review revealed that both pharmacological and non-pharmacological methods of treatment may be useful in the clinical improvement of schizophrenia.

Share
without publication fees
without publication fees